BioFront Technologies Receives Funding Through Florida Institute Seed Capital Accelerator Program
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
GAINESVILLE & BOCA RATON, Fla.--(BUSINESS WIRE)--The Institute for the Commercialization of Public Research (the Institute) announced today that it has finalized a funding agreement with BioFront Technologies, producers of diagnostic kits and reagents that detect viral and allergenic proteins for food safety and infectious disease markets. Working with Florida’s research universities and institutions to support new company creation and job growth, the Institute’s Seed Capital Accelerator Program bridges early funding gaps, requiring recipients to raise private matching investment which enables them to reach critical development milestones and get to market quicker.
Help employers find you! Check out all the jobs and post your resume.
GAINESVILLE & BOCA RATON, Fla.--(BUSINESS WIRE)--The Institute for the Commercialization of Public Research (the Institute) announced today that it has finalized a funding agreement with BioFront Technologies, producers of diagnostic kits and reagents that detect viral and allergenic proteins for food safety and infectious disease markets. Working with Florida’s research universities and institutions to support new company creation and job growth, the Institute’s Seed Capital Accelerator Program bridges early funding gaps, requiring recipients to raise private matching investment which enables them to reach critical development milestones and get to market quicker.
Help employers find you! Check out all the jobs and post your resume.